Pretransplant Evaluation and Cardiac Risk Assessment

  • Khalid Khwaja
  • Abhinav Humar


One crucial factor in ensuring successful outcomes after pancreas transplants is the comprehensive pretransplant evaluation of potential recipients. Proper patient selection is obviously key in any transplant procedure. But, identifying obvious contraindications or excluding poor candidates is only one small aspect of the pretransplant evaluation. Candidates classified as “high risk” may not necessarily have absolute contraindications to surgery; with proper preparation, they can expect to have a good chance for a successful outcome posttransplant. Therefore, a more important goal of the pretransplant evaluation should be to prepare the potential recipient so that he or she is in the best possible condition by the time the transplant is performed. This preparation involves identifying any significant risk factors that could be altered and dealing with medical problems that may lead to complications peri- or posttransplant. Even risk factors that cannot be altered are best identified pretransplant because they may affect posttransplant care. The potential recipient must also be psychologically prepared for the transplant, ideally through providing education on the many different aspects of transplantation.


Living Donor Constrictive Pericarditis Pancreas Transplant Dobutamine Stress Echocardiography Transplant Candidate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Sutherland DER, Gruessner RGW, Humar A, Kandaswamy R, Najarian JS, Dunn DL, Gruessner A. Pretransplant immunosuppression for pancreas transplants alone in nonuremic diabetic recipients. Transplant Proc 2001; 33: 1656–1658.PubMedCrossRefGoogle Scholar
  2. 2.
    Penn I. The effect of immunosuppression on pre-existing cancers. Transplantation 1993; 55: 742–747.PubMedCrossRefGoogle Scholar
  3. 3.
    Kasiske BL, Ramos EL, Gaston RS, Bia MJ, Danovitch GM, Bowen PA, Lundin PA, and Murphy KJ. The evaluation of renal transplant candidates- Clinical practice guidelines. J Am Soc Nephrol 1995; 6: 1–34.PubMedGoogle Scholar
  4. 4.
    Quinibi WY, Al-Sibai MB, Taher S, et al. Mycobacterial infection after renal transplantation-report of 14 cases and review of the literature. Q J Med 1990; 77: 1039–1060.CrossRefGoogle Scholar
  5. 5.
    Rubin RH, Jenkins RL, Shaw BS Jr, et al. The acquired immunodeficiency syndrome and transplantation. Transplantation 1987; 44: 1–4.PubMedCrossRefGoogle Scholar
  6. 6.
    Kuo PC, Stock PG. Transplantation in the HIV+ patient. Am J Transplant 2001; 1: 13–17.PubMedCrossRefGoogle Scholar
  7. 7.
    Weir MR, Irwin BC, Maters AW, et al. Incidence of cytomegalovirus disease in cyclosporine-treated renal transplant recipients based on donor-recipient pre-transplant immunity. Transplantation 1987; 43: 187–191.PubMedCrossRefGoogle Scholar
  8. 8.
    Green M. Management of Epstein-Barr virus induced post-transplant lymphoproliferative disease in recipients of solid organ transplantation. Am J Transplant 2001; 1: 103–108.PubMedGoogle Scholar
  9. 9.
    Hiesse C, Buffet C, Neyrat N, et al. Impact of hepatitis B antigenemia on long-term patient survival and causes of death after renal transplantation. Clin Transplant 1992; 46: 461–467.Google Scholar
  10. 10.
    Stempel CA, Lake J, Kuo G, Vincenti F. Hepatitis C-its prevalence in end-stage renal failure patients and clinical course after kidney transplantation. Transplantation 1993; 55: 273–276.PubMedCrossRefGoogle Scholar
  11. 11.
    Legendre C, Garrigue V, Le Bihan C, et al. Harmful long-term impact of hepatitis C virus infection in kidney transplant recipients. Transplantation 1998; 65: 667–670.PubMedCrossRefGoogle Scholar
  12. 12.
    Popkin MK, Callies AL, Lentz RD, et al. Prevalence of major depression, simple phobia, and other psychiatric disorders in patients with long-standing type I diabetes mellitus. Arch Gen Psychiatry 1998; 45: 64–68.CrossRefGoogle Scholar
  13. 13.
    Popkin MK, Callies AL, Colon EA. Psychiatric diagnosis and the surgical outcome of pancreas transplantation in patients with type I diabetes mellitus. Psychosomatics 1993; 34: 251–258.PubMedCrossRefGoogle Scholar
  14. 14.
    Manske CL, Thomas W, Wang Y, Wilson RF. Screening diabetic transplant candidates for coronary artery disease: Identification of a low-risk subgroup. Kidney Int 1993; 44: 617–621.PubMedCrossRefGoogle Scholar
  15. 15.
    Vandenberg BF, Rossen JD, Grover-McKay M, et al. Evaluation of diabetic patients for renal and pancreas transplantation: Noninvasive screening for coronary artery disease using radionuclide methods. Transplantation 1996; 62: 1230–1235.PubMedCrossRefGoogle Scholar
  16. 16.
    Bates JR, Sawada SG, Segar DS, Spaedy AJ, et al. Evaluation using dobutamine stress echocardiography in patients with insulin-dependent diabetes mellitus before kidney and/or pancreas transplantation. Am J Cardiol 1996; 77: 175–179.PubMedCrossRefGoogle Scholar
  17. 17.
    Herzog CA, Marwick TH, Pheley AM, White C, et al. Dobutamine stress echocardiography for the detection of significant coronary artery disease in renal transplant candidates. Am J Kidney Dis 1999; 33: 1080–1090.PubMedCrossRefGoogle Scholar
  18. 18.
    Manske CL, Wang Y, Rector T, Wilson RF, White CW. Coronary revascularisation in insulin-dependent diabetic patients with chronic renal failure. Lancet 1992; 340: 998–1002.PubMedCrossRefGoogle Scholar
  19. 19.
    Kalker AJ, Pirsch JD, Heisey D, et al. Foot problems in diabetic transplant recipients. Clin Transplant 1996; 10: 503–510.PubMedGoogle Scholar
  20. 20.
    Brown MM, Humphrey PR. Carotid endarterectomy-specific therapy based on pathophysicology. N Engl J Med 1991; 325: 505–507.CrossRefGoogle Scholar
  21. 21.
    Chiu MY, Sprague SM, Bruce DS, Woodle ES, et al. Analysis of fracture prevalence in kidney-pancreas allograft recipients. J Am Soc Nephrol 1998; 9: 677–683.PubMedGoogle Scholar
  22. 22.
    Humar A, Kandaswamy R, Drangstveit MB, et al. Surgical complications in obese pancreas transplant recipients. Transplantation 2000; 69: S212.Google Scholar
  23. 23.
    Humar A, Kandaswamy R, Ramcharan T, et al. A multivariate analysis of risk factors for acute rejection in pancreas transplant recipients. Am J Transplant 2001; 1 (suppl 1): 212.Google Scholar
  24. 24.
    Humar A, Ramcharan T, Kandaswamy R, et al. Pancreas after kidney transplant. Am J Surg 2001; 182 (2): 155–161.PubMedCrossRefGoogle Scholar
  25. 25.
    Sutherland DE, Gruessner RW, Dunn DL, et al. Lessons learned from more than 1,000 pancreas transplants at a single institution. Ann Surg 2001; 233: 463–501.PubMedCrossRefGoogle Scholar
  26. 26.
    Farney AC, Cho E, Schweitzer E, et al. Simultaneous cadaver pancreas living-donor kidney transplantation: A new approach for the type 1 diabetic uremic patient. Ann Surg 2000; 232: 696–703.PubMedCrossRefGoogle Scholar
  27. 27.
    Gruessner RW, Sutherland DE, Drangstveit MB, Bland BJ, Gruessner AC. Pancreas transplants from living donors: Short-and long-term outcomes. Transplant Proc 2001; 33 (1/2): 819–820.PubMedCrossRefGoogle Scholar
  28. 28.
    Humar A, Gruessner R, Sutherland D. Living related donor pancreas and pancreas-kidney transplantation. Br Med Bull 1997;53(4).Google Scholar
  29. 29.
    Gruessner RW, Dunn DL, Gruessner AC, Matas M, Najarian JS, Sutherland DE. Recipient risk factors have an impact on technical failure and patient and graft survival rates in bladder-drained pancreas transplants. Transplantation 1994; 57: 1598–1606.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2004

Authors and Affiliations

  • Khalid Khwaja
  • Abhinav Humar

There are no affiliations available

Personalised recommendations